Vaginal specimens for culture were obtained from two hundred and five immun
ocompetent, non-hospitalized patients selected among all women attending th
e Gynecology and Obstetric Ambulatory Clinic of the University of Espirito
Santo, Brazil, during a 2-year period (From 1998 to 1999). Patients were ch
ecked for signs and symptoms of vulvovaginitis and previous use of topical
and systemic antifungal drugs. Yeast isolates were identified by classical
methods and the antifungal susceptibility profile was determined according
to NCCLS microbroth assay.
The prevalence of vaginal yeast isolates from asymptomatic women was 25% (3
0/121) and 60% (50/84) among patients with symptoms of vulvovaginitis. Cand
ida albicans was the most frequently isolated species in both groups (46% a
nd 90%, respectively), followed by C. glabrata (13% and 6%, respectively).
All isolates were susceptible to amphotericin B. Only ten isolates had dose
dependent susceptibility (DDS) or resistance to azoles; and seven of these
were non-albicans species.
Based on our results we suggest that species identification and antifungal
susceptibility testing need not be routinely performed in immunocompetent w
omen, and may be reasonable only for the minority of patients with complica
ted vulvovaginal candidiasis that fail to respond to therapy.